Status:
COMPLETED
Clinical Testing of the Cortrium C3 Device
Lead Sponsor:
Cortrium
Collaborating Sponsors:
University College Absalon
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Clinical data validation of the C3 device as a Vital Sign Monitoring System for patients under cancer treatment.
Detailed Description
Cortrium has developed the C3 device. The C3 device contains sensors that monitors Electrocardiogram (ECG), Respiratory rate (breathes per minute), and Body surface temperature. Also, the C3 device co...
Eligibility Criteria
Inclusion
- Legally competent persons - i.e., patients considered able to understand the information given about the clinical trial
- Person is 18 years or older
- Person has given a written informed consent
Exclusion
- Not legally competent patients
- Pregnant and lactating women
- Fertile women, who do not use contraceptives
- Patients under 18 years
- Patients with known heart-related disease
Key Trial Info
Start Date :
May 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 26 2019
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03387891
Start Date
May 3 2017
End Date
September 26 2019
Last Update
December 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Schleswig-Holstein, Campus Lübeck
Lübeck, Schleswig-Holstein, Germany, 23538